Hallie A. Carol, MD
Hallie A. Carol, MD

Hallie A. Carol, MD

Hallie A. Carol, MD, is a fellow with the Division of Rheumatology at Children's Hospital of Philadelphia.


215-590-2547

About Hallie A. Carol, MD

Titles

Fellow

Awards and Honors

2020, PL-1 Resident Teacher of the Year Award, Ann & Robert Lurie Children’s Hospital of Chicago
2020, Feinberg School of Medicine Recognition for Exemplary Professionalism
2019, William Perry Watson Prize
2019, Graduation Class History Speaker, Columbia University College of Physicians and Surgeons
2018, Gold Humanism Honor Society, Columbia University College of Physicians and Surgeons
2017, Karl H. Perzin Excellence in Pathology Award, Columbia University College of Physicians and Surgeons
2014, Magna Cum Laude, Bowdoin College
2014, Phi Beta Kappa, Bowdoin College
2012, Bowdoin College Book Award
2012-2014, Sarah and James Bowdoin Scholar

Leadership and Memberships

Memberships in Professional Organizations

2021-present, Childhood Arthritis and Rheumatology Research Alliance (CARRA)
2021-present, Clinical Immunology Society
2019-present, American Academy of Pediatrics
2018-present, Gold Humanism
2014-present, Phi Beta Kappa

Education & training

Medical Degree

MD - Columbia University College of Physicians and Surgeons, New York, NY

Residency

Pediatrics - McGaw Medical Center of Northwestern University, Chicago, IL

Fellowship

Pediatric Rheumatology - Children's Hospital of Philadelphia, Phildelphia, PA

Team affiliations

 View fewer team affiliations View all team affiliations

Publications

Publications

2022

Gunderman LM, Valika T, Carol H, Khojah A. Improvement of SLC29A3 spectrum disorder-related sensorineural hearing loss after initiation of IL-6 inhibitor. BMJ Case Rep. 2022 Jun 22;15(6):e249191. doi: 10.1136/bcr-2022-249191. PMID: 35732371; PMCID: PMC9226926.

Carol, HA, Ochfeld EN, and Ahmed, A. In-Utero Exposure to Immunosuppressive Medications Resulting in Abnormal Newborn Screening for Severe Combined Immunodeficiency: A Case Series on Natural History and Management. Immunologic Research. 2022, June.

2021

Carol, H., Padem, N., Valika., T., and Khojah, A. Abstract: Improvement of SLC29A3 spectrum disorder-related sensorineural hearing loss after initiation if IL-6 inhibitor. Journal of Clinical Immunology (2021). https://doi.org/10.1007/s10875-021-01001-x.

2020

Moulton, KD., Adewale, AP., Carol, HA., Mikami, SA., and Dube, DH. Metabolic glycan labeling-based screen to identify bacterial glycosylation genes. ACS Infectious Diseases. 2020, Nov; 6 (12): 3247-3259. https://doi.org/10.1021/acsinfecdis.0c00612

2019

Gusev, A., Spisak, S., Abbasi, F., …, Carol, H., …, Freedman, M. Abstract SY25-02: Widespread germline-somatic regulatory differences in renal cell carcinoma prioritize risk mechanisms. Epidemiology. American Association for Cancer Research; 2019. July. http://doi.org/10.1158/1538-7445.AM2019-SY25-02

Laskar, R., Muller, D., Li, P., ..., Carol, HA., ..., Purdue, M. Sex Specific Associations in Genome Wide Association Analysis of Renal Cell Carcinoma. European Journal of Human Genetics. 2019, June; 27, 1589-1598. https://doi.org/10.1038/s41431-019-0455-9

Gusev, A., Spisak, S., Fay, A., Carol, H., …, Freedman, M. Allelic Imbalance reveals widespread germline-somatic regulatory differences and prioritizes risk loci in Renal Cell Carcinoma. bioRxiv. 2019, May. 631150; DOI: https://doi.org/10.1101/631150

Johansson, M., Carreras-Torres, R., Scelo, G., ..., Carol, H.A., ..., Brennan, P. The influence of obesity-related factors in the etiology of renal cell carcinoma - A Mendelian randomization study. PLOS Medicine. 2019, Jan; 16(1): e1002724. https://doi.org/10.1371/journal.pmed.1002724

2017

Machiela, M.J., Hofmann, J.N., Carreras-Torres, R., ..., Carol, H.A., ..., Purdue, M. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma. European urology. 2017, Nov; 72(5): 747-754. Cited in PubMed; PMID: 28797570.

Scelo, G., Purdue, M.P., Brown, K.M., ..., Carol, H.A., ..., Chanock, S.J. Genome-wide association study identifies multiple risk loci for renal cell carcinoma. Nature Communications. 2017, Jun; 8(15724): 1-9. Cited in PubMed; PMID: 28598434.

2016

de Velasco, G., Gray K.P., Hamieh, L., …, Carol, H.A., …, Choueiri, T.K.. Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma. European Urology Focus. 2016, Dec; 2(6): 633-639. Cited in PubMed; PMID: 28723497.

2015

Dube, D., Mikai, S., and Carol, H.. Analysis of Helicobacter pylori strains deficient in protein glycosylation. Abstracts of papers of the American Chemical Society (Vol 249). American Chemical Society. 2015.

Albiges, L., De Velasco, G., Gray, K., Carol, H., ... & Choueiri, T,. The impact of MET expression on patient outcomes with metastatic renal cell carcinoma (mRCC) treated with VEGF-targeted therapy (TT). BJU International. 2015. Dec, 116, 1-2.

Patient experience rating

(based on 33 submissions)
  • Provider listened carefully
    4.7 of 5
  • Trust provider with care
    4.7 of 5
  • Provider gave enough info about child's health
    4.7 of 5
  • Would recommend the provider
    4.6 of 5
Learn about the patient experience rating system

About the Patient Experience Rating System

The patient experience rating is an average of all responses to the care provider-related questions from surveys submitted by patient families and verified by our survey partner National Research Corporation (NRC Health), an independent company that specializes in patient experience. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured using percent positive scoring. Percent positive is the percentage of respondents who answered with the most desirable response. We are committed to transparency and sharing the voices of our patients and families. Comments are reviewed before posting to ensure accuracy, privacy, and relevance. To provide meaningful feedback, comments are displayed on provider profiles once a sufficient number have been received. All feedback is also shared internally to support learning, recognition, and continuous improvement. The comments reflect the experiences and perspectives of the patients and families who submitted them. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.